Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance

World Journal of Gastroenterology

Volumn 15, Issue 14, 2009, Pages 1786-1787

  Lobb, Ano ^a  

^a NONE   (United States)

Author keywords

Dietary supplements; Garcinia cambogia; Hca sx; Hydroxycut; Liver failure; Super citrimax; Weight loss

Indexed keywords

ANTIOBESITY AGENT; HYDROXYCUT; UNCLASSIFIED DRUG;

ARTICLE; CONSUMER ADVOCACY; DRUG EFFICACY; DRUG SAFETY; EPHEDRA; FOOD AND DRUG ADMINISTRATION; GARCINIA CAMBOGIA; HUMAN; LIVER DYSFUNCTION; LIVER TOXICITY; POSTMARKETING SURVEILLANCE; PUBLIC HEALTH; SUPPLEMENTATION; UNITED STATES; WEIGHT REDUCTION; ADULT; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; LETTER; LIVER; MALE; MARKETING; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-OBESITY AGENTS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LIVER; MALE; MARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WEIGHT LOSS; YOUNG ADULT;

EID: 65649093745     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1786     Document Type: Article

References (17)

1. Dara L, Hewett J, Lim JK. Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008; 14: 6999-7004
2. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005; 142: 477-478
3. Shim M, Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009; 54: 406-408
4. Jones FJ, Andrews AH. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol 2007; 102: 2357-2358
5. Blanck HM, Serdula MK, Gillespie C, Galuska DA, Sharpe PA, Conway JM, Khan LK, Ainsworth BE. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007; 107: 441-447
6. Weight control a high priority. Chain Drug Rev 2008; 30: 30
7. Consumers Union. Dangerous supplements: still at large. Consum Rep 2004; 69: 12-17
8. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008; 23: 854-859
9. Morrow JD. Why the United States still needs improved dietary supplement regulation and oversight. Clin Pharmacol Ther 2008; 83: 391-393
10. United States General Accounting Office. Dietary supplements for weight loss: Limited federal oversight has focused more on marketing than on safety. 2002. Available from: URL: http://www.gao.gov/new.items/ d02985t.pdf
11. Gardiner P, Sarma DN, Low Dog T, Barrett ML, Chavez ML, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI. The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2008; 17: 962-970
12. U.S. Food and Drug Administration. Medwatch: The FDA safety information and adverse event reporting program. Search performed on January 24, 2009. Available from: URL: http://www.fda.gov/medwatch
13. U.S. Food and Drug Administration. Sales of supplements containing ephedrine alkaloids (ephedra) prohibited. 2004. Available from: URL: http://www.fda.gov/oc/initiatives/ephedra/february2004
14. Moran M. Did delay of ephedra ban cause unnecessary deaths? Psych News 2004; 39: 24
15. Boon HS, Wong AH. Kava: a test case for Canada's new approach to natural health products. CMAJ 2003; 169: 1163-1164
16. Medicines and Healthcare Products Regulatory Agency. MCA investigation of kava-kava leads to ban following voluntary withdrawal. 2002. Available from: URL: http://www.dh.gov.uk/en/ Publicationsandstatistics/Pressreleases/DH_4026015
17. U.S. Food and Drug Administration. Kava-containing dietary supplements may be associated with severe liver injury. Consumer advisory, 2002-03-25. Available from: URL: http://www.cfsan.fda.gov/~dms/ addskava.html